Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
✍ Scribed by K. Selmaj; Dr. C. S. Raine; A. H. Cross
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 734 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
disease, 2 with pleural disease, and 1 each with paravertebral, meningeal, genital, bladder, enteric, and bone disease.
## Abstract ## Objective To examine the rates of and risk factors for neutropenia together with the dynamics of neutrophil and other white cell subset counts in a cohort of patients treated with a tumor necrosis factor (TNF) inhibitor for inflammatory arthritis. ## Methods We performed a retrosp
We read with great interest the article by Cavazza et al., 1 who demonstrated that an advanced histological stage was the only risk factor associated with the development of hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) from two European centers. Similar results wer